A UK man’s “aggressive” brain tumor was cut down in size by “50%” following a first-of-its-kind treatment for a type of cancer that typically kills patients within 18 ...
Bill Sibold, Chief Executive Officer of Madrigal, stated, “This will be the first AASLD Liver Meeting following the approval of Rezdiffra earlier this year, and the entire NASH community feels ...